Sign in:
 Email
 Password  save:
  
 Company Reports 
 
 
Membership is free, please Sign Up.
  
My Recent Searches
  Help
  
   
 
 
Get Insiders for : 
Alnylam Pharmaceuticals Inc (ALNY)  
$149.30 2.76 (1.82%) as of 4:30 Thu 6/6


Download
   
Exchange: Nasdaq National Market
Security Type: Common
Shares Out: 123,030,000
Market Cap: 18.37(B)
Last Volume: 534,229 Avg Vol: 722,222
52 Week Range: $143.31 - $211.65
Level I Sector: Health Care
Level II Sector: Drugs
Level III Sector: Biotechnology

Member Indexes:
    NASDAQ BIOTECHNOLOGY     NASDAQ COMPOSITE
    NASDAQ NNM COMPOSITE

Rankings:
     
Insider 3 Months    :   -
Insider 6 Months    :   -
Insider 3/6 Months :   -
Guru Rank Number :  824
Guru Rank Value     : 0.5
Guru Occurances    : 1

 

            6 Months   1 Year   2 Year  
 
Company Profile   Alnylam Pharmaceuticals is a commercial-stage biopharmaceutical company developing therapeutics based on RNA interference. Co. has four RNAi-based medicines, ONPATTRO® (patisiran), GIVLAARI® (givosiran), OXLUMO™ (lumasiran) and Leqvio® (inclisiran). ONPATTRO is approved for the treatment of the polyneuropathy of hereditary transthyretin-mediated amyloidosis in adults. GIVLAARI is approved for the treatment of adults with acute hepatic porphyria. Co. has approval for OXLUMO for the treatment of hyperoxaluria type 1 (PH1) in all age groups. Leqvio (inclisiran) is being developed for the treatment of adults with hypercholesterolemia or mixed dyslipidemia.

 
 
Summary  (Direct Transactions Only) 3 Months 6 Months 12 Months 24 Months
Total Shares Bought 0 0 0 0
Total Buy Value $0 $0 $0 $0
Total People Bought 0 0 0 0
Total Buy Transactions 0 0 0 0
Total Shares Sold 21,700 98,555 124,204 268,793
Total Sell Value $3,224,546 $16,182,261 $20,937,886 $52,053,725
Total People Sold 1 8 9 10
Total Sell Transactions 1 13 19 36
End Date 2024-03-07 2023-12-05 2023-06-06 2022-06-06

   
Records found: 748
  Page 26 of 30  
Filer's Name Relation Title Off-Dir-10% Tran. Date Form Action Price Mkt Value D/I Shares Holdings
Rank

  
3m +/-  
Form
   Maraganore John CEO   •       •      –    2008-08-18 4 GD $0.00 $0 D/D 750 0     -
   Maraganore John CEO   •       •      –    2008-08-18 4 OE $0.48 $356 D/D 750 750     -
   Maraganore John CEO   •       •      –    2008-08-14 4 AS $34.23 $1,283,512 D/D (37,500) 0     -
   Maraganore John CEO   •       •      –    2008-08-14 4 OE $0.48 $17,813 D/D 37,500 37,500     -
   Greene Barry E President and COO   •       –      –    2008-08-13 4 AS $33.92 $1,202,726 D/D (35,440) 0     -
   Greene Barry E President and COO   •       –      –    2008-08-13 4 OE $0.95 $29,345 D/D 30,889 30,889     -
   Maraganore John CEO   •       •      –    2008-08-13 4 AS $33.95 $1,273,005 D/D (37,500) 0     -
   Maraganore John CEO   •       •      –    2008-08-13 4 OE $0.48 $17,813 D/D 37,500 37,500     -
   Maraganore John CEO   •       •      –    2008-06-30 4 GD $0.00 $0 D/D 3,000 0     -
   Maraganore John CEO   •       •      –    2008-06-30 4 OE $0.48 $1,425 D/D 3,000 3,000     -
   Novartis Pharma Ag 10% Owner   –       –       •   2008-05-08 4 B $25.29 $5,409,228 I/I 213,888 5,481,753 1.5     -
   Schimmel Paul Director   –       •      –    2007-12-04 4 S $31.85 $229,364 I/I (7,192) 62,385     -
   Schimmel Paul Director   –       •      –    2007-12-03 4 S $32.30 $377,669 I/I (11,586) 69,577     -
   Schimmel Paul Director   –       •      –    2007-12-03 4 GD $0.00 $0 D/D 4,000 234,088     -
   Schimmel Paul Director   –       •      –    2007-11-30 4 S $32.90 $569,177 I/I (17,222) 81,163     -
   Schimmel Paul Director   –       •      –    2007-11-30 4 S $33.50 $673,957 D/D (20,000) 238,088     -
   Schimmel Paul Director   –       •      –    2007-11-30 4 OE $7.08 $218,200 D/D 20,000 258,088     -
   Allen Patricia L VP of Finance/Treasurer   •       –      –    2007-10-25 4 AS $32.06 $199,141 D/D (6,190) 1,070     -
   Allen Patricia L VP of Finance/Treasurer   •       –      –    2007-10-25 4 AS $31.54 $439,990 D/D (13,810) 7,260     -
   Allen Patricia L VP of Finance/Treasurer   •       –      –    2007-10-25 4 OE $0.95 $19,000 D/D 20,000 21,070     -
   Greene Barry E COO   •       –      –    2007-10-24 4 AS $30.95 $329,373 D/D (10,580) 9,771     -
   Greene Barry E COO   •       –      –    2007-10-24 4 AS $30.62 $669,359 D/D (21,700) 20,351     -
   Greene Barry E COO   •       –      –    2007-10-24 4 AS $31.36 $165,126 D/D (5,220) 4,551     -
   Maraganore John CEO   •       •      –    2007-06-29 4 AS $15.60 $269,298 D/D (17,089) 1,689     -
   Maraganore John CEO   •       •      –    2007-06-29 4 AS $16.11 $27,371 D/D (1,689) 0     -
  748 Records found
  Previous  20  21  22  23  24  25  26  27  28  29  Next   
  Page 26 of 30
  Transaction Code Key: Ownership Code Key
  B - Buy AB - Automatic Buy D - Direct Ownership
  S - Sell AS - Automatic Sell I - Indirect Ownership
  OE - Options Exercised A - Acquired
  IO - Initital Ownership D - Disposed
 
 
    Copyright © 2024 j3sg.com | Disclaimer & Terms of use          Products & Service  About Us  Contact Us